Professional
Added to YB: 2024-03-01
Pitch date: 2024-02-29
ICUI [neutral]
ICU Medical, Inc.
+38.73%
current return
Author Info
No bio for this author
Company Info
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide.
Market Cap
$3.4B
Pitch Price
$106.99
Price Target
161.00 (+8%)
Dividend
N/A
EV/EBITDA
12.59
P/E
-437.17
EV/Sales
1.92
Sector
Health Care Equipment and Supplies
Category
turnaround
ICU Medical, Inc.: Normalizing Operations Bring Additional Synergies With Smiths Integration
$ICUI FV cut to $161 on conservative '24 outlook & Smiths integration delays. Q4 rev +2%, inventory spend -$195M. Integration done 2025; long-term synergies promising despite challenges. Aims for broader portfolio; some durable advantages remain. Low single-digit rev growth thru '28, EPS to outpace. Risks: client loss, quality/FDA hurdles, competition.
Read full article (7 min)